NutraSift: The nutraceutical innovation podcast

Ginger- Drying ginger creates a different drug

5 min · 15 jun 2026
aflevering Ginger- Drying ginger creates a different drug artwork

Beschrijving

Fresh ginger is rich in 6-gingerol. Drying converts gingerols to shogaols. 6-Shogaol is 2-3x more potent than 6-gingerol for anti-inflammatory activity and activates TRPV1 (pain receptor). This means dried ginger extract is pharmacologically different from fresh ginger extract. Although the processing method creates a different medicine, most product labels don't distinguish between the two. Publications of interest: https://pubmed.ncbi.nlm.nih.gov/29976903/, https://pmc.ncbi.nlm.nih.gov/articles/PMC6692589/, https://pubmed.ncbi.nlm.nih.gov/19833188/

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de NutraSift: The nutraceutical innovation podcast community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

78 afleveringen

aflevering Can social media serve as Real-Word Data for supplements? artwork

Can social media serve as Real-Word Data for supplements?

What if the millions of supplement experiences shared online could point us toward what actually works? We dig into a first-of-its-kind study that matched 216,350 Reddit comments against 15,760 clinical-trial records to test whether social media chatter lines up with real evidence. The findings are striking: the most-discussed ingredients were more than 3× as likely to have trial evidence behind them (39% vs. 11%), and the effect scaled steadily. The more a benefit was discussed, the stronger its link to clinical support (odds ratios climbing from 2.1 to 5.5). We unpack why this matters. Supplements largely escape the post-market surveillance that tracks prescription drugs, leaving over-the-counter use nearly invisible, even as lived experiences pile up in public forums. We explore how consensus (not just volume) carries independent signal, how contested claims might hint at personalised supplementation, and why aggregated social data, treated carefully as a measurement instrument, could become a credible real-world resource for prioritising hypotheses and designing sharper studies. Not a replacement for clinical trials, but a powerful new lens. You can find the full publication: https://www.medrxiv.org/content/10.64898/2026.06.26.26356690v1 [https://www.medrxiv.org/content/10.64898/2026.06.26.26356690v1]

Gisteren9 min